We also examined the expression of Col1a1 as a fibrosis marker and Saa1 as an inflammatory marker since they have been reported to be highly correlated with advanced stages of MASLD (38, 39). Here, SAA1 is linked to metabolic dysfunction-associated steatotic liver disease.